Permanent Supportive Housing Overdose Prevention+ Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
This community-partnered study examines a technical assistance intervention designed to help permanent supportive housing agencies implement evidence-based practices to prevent tenant overdose and improve tenant health.
Eligibility criteria
Qualifiers
Serve at least 40 tenants in New York and/or New Jersey
Have a significant concern for overdose (as demonstrated by past year tenant overdose)
Be willing to complete all activities required for participation in the trial
Must live in an enrolled Supportive Housing Agency
Disqualifiers
See inclusion criteria.
Trial design
Treatments tested in this trial
- TA Intervention
Treatment groups
2,940 Participants
are divided into 4 treatment groupsSponsors and collaborators
NYU Langone Health
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
Source ClinicalTrials.gov